A cross-sectional study analyzed survey data of U.S. adults to compare the benefits of race-aware versus race-unaware predictions for disease risk. The analysis found that the clinical net benefit of ...
According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer survival; however, rates have improved in the last 5 years regardless.